Consistent with this possibility, deep ZC3H18 deletions and low ZC3H18 mRNA levels are nearly mutually exclusive with BRCA1 driver mutations and deep deletions in ovarian tumors analyzed by The Cancer Genome Atlas research network (Supplementary Fig. 10). This evidence concerns the gene ZC3H18 and ovarian neoplasm.